The Role of Ribonucleotide Reductase M2 in Lung Cancer Progression and Chemotherapy Resistance: A Bioinformatics Analysis and Review.

IF 2.9 4区医学 Q2 PHARMACOLOGY & PHARMACY

American journal of therapeutics Pub Date : 2024-11-11 DOI:10.1097/MJT.0000000000001827

Jin-Jie Wang, Shui-Ying Zhou, Ming Zhao, Hai-Long Tang, De-Shen Shan, Hao Wang

引用次数: 0

查看原文本刊更多论文

核糖核苷酸还原酶 M2 在肺癌进展和化疗耐药性中的作用：生物信息学分析与综述

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American journal of therapeutics PHARMACOLOGY & PHARMACY-

CiteScore

5.50

自引率

9.50%

发文量

142

审稿时长

6-12 weeks

期刊介绍： American Journal of Therapeutics is an indispensable resource for all prescribing physicians who want to access pharmacological developments in cardiology, infectious disease, oncology, anesthesiology, nephrology, toxicology, and psychotropics without having to sift through stacks of medical journals. The journal features original articles on the latest therapeutic approaches as well as critical articles on the drug approval process and therapeutic reviews covering pharmacokinetics, regulatory affairs, pediatric clinical pharmacology, hypertension, metabolism, and drug delivery systems.